Pnc Financial Services Group, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $678 - $1,211	-392 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.81 - $10.93 $1,184 - $1,901	174 Added 79.82%	392 $2,000
Q2 2020 Aug 07, 2020	SELL	$2.97 - $5.22 $26 - $46	-9 Reduced 3.96%	218 $1,000
Q1 2020 May 08, 2020	SELL	$2.67 - $4.97 $189 - $352	-71 Reduced 23.83%	227 $0
Q4 2019 Feb 07, 2020	BUY	$2.93 - $4.5 $205 - $315	70 Added 30.7%	298 $1,000
Q3 2019 Nov 08, 2019	BUY	$3.08 - $5.76 $357 - $668	116 Added 103.57%	228 $0
Q2 2019 Aug 09, 2019	SELL	$3.47 - $6.32 $93 - $170	-27 Reduced 19.42%	112 $0
Q1 2019 May 10, 2019	BUY	$5.36 - $7.24 $48 - $65	9 Added 6.92%	139 $0
Q4 2018 Feb 08, 2019	BUY	$4.8 - $11.6 $86 - $208	18 Added 16.07%	130 $0
Q2 2018 Aug 10, 2018	SELL	$10.2 - $13.9 $8,976 - $12,232	-880 Reduced 88.71%	112 $0
Q1 2018 May 11, 2018	BUY	$12.65 - $18.85 $759 - $1,131	60 Added 6.44%	992 $0
Q4 2017 Feb 09, 2018	BUY	$17.45 - $25.6 $907 - $1,331	52 Added 5.91%	932 $0
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $16,632 - $24,816	880	880 $0

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.